Latest Insulin glargine Stories

2014-01-31 12:25:16

INDIANAPOLIS, Jan. 31, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has provided the following statement regarding a lawsuit filed by Sanofi in the United States District Court for the District of Delaware alleging patent infringement with respect to LY2963016, a new insulin glargine product for which Lilly is currently seeking approval from the U.S. Food and Drug Administration (FDA). "Lilly respects the intellectual property of others and does not believe the...

2013-09-25 23:35:19

AffordRx.com now offers Lantus coupons for children with diabetes. Houston, TX (PRWEB) September 25, 2013 Healthcare continues to be a hot debate and seems to be the topic of conversation everywhere – from the classroom to the dinner table. Reports from the Centers for Disease Control and Prevention show that over 45 million Americans were without health insurance in 2012. Another 10 million people were without insurance for at least part of that year. These are staggering statistics...

2013-09-24 23:00:09

RnRMarketResearch.com adds a new report “Type 2 Diabetes Market to 2019 – A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019” to its store. The report says the market is led by Lantus, which achieved global sales amounting to $6.4 billion in 2012. Dallas, Texas (PRWEB) September 25, 2013 There are currently a large number of blood glucose-lowering drugs in the crowded type 2 diabetes market indicated for the treatment of chronically high...

2013-06-18 19:29:26

Insulin degludec (Tresiba), a new ultra-long-acting insulin, has a similar or reduced risk of recurrent hypoglycemia-- low blood sugar-- compared with the commercially available insulin glargine, a new meta-analysis study finds. Results of the combined analysis, of five completed clinical trials, will be presented Tuesday at The Endocrine Society's 95th Annual Meeting in San Francisco. The studies included nearly 3,400 adults with type 2 diabetes who had a daily injection of either insulin...

Word of the Day
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.